原发免疫性血小板减少症患者脾脏中Treg细胞与Th17细胞的数量
该研究纳入2008年12月至2016年6月在福建医科大学附属协和医院接受脾切除术的43例成人ITP患者及30例因胰腺疾病或脾外伤行脾切除术的对照,用免疫组化检测脾脏Treg与Th17细胞。ITP组脾脏Treg细胞少于对照、Th17细胞多于对照、Treg/Th17比值低于对照;脾切除无效者Treg细胞少于有效者,Th17细胞数与Treg/Th17比值两组差异无统计学意义。
要点
- ITP患者脾脏Treg细胞少于对照,Th17细胞多于对照,Treg/Th17比值低于对照。
- 脾切除无效者脾脏Treg细胞少于有效者,Th17细胞数与Treg/Th17比值两组无显著差异。
- 作者认为脾脏Treg、Th17细胞数量改变可能与脾切除术疗效有一定关联。
核心结论
- 成人ITP患者脾脏组织中Treg细胞与Th17细胞数量有显著改变,可能与脾切除术疗效有一定关联。
研究设计与样本
- 研究纳入2008年12月1日至2016年6月30日在福建医科大学附属协和医院接受脾切除术的43例成人ITP患者,男20例、女23例,中位年龄36(18~76)岁。
- 对照为30例因胰腺疾病或脾外伤接受脾切除术的患者,男21例、女9例,中位年龄47(21~69)岁。
- 采用免疫组化技术观察脾脏组织Treg细胞与Th17细胞数量并计算Treg/Th17细胞比值。
主要发现
- ITP组脾脏Treg细胞少于对照组[(11.3±4.7)个/mm²对(59.0±15.0)个/mm²,t=-22.894,P<0.001]。
- ITP组脾脏Th17细胞多于对照组[(235.2±69.4)个/mm²对(181.1±23.7)个/mm²,t=13.768,P<0.001]。
- ITP组Treg/Th17细胞比值低于对照组(0.048±0.027对0.328±0.086,t=19.522,P<0.001)。
- 脾切除术无效ITP患者脾脏Treg细胞少于有效患者[(9.5±5.0)个/mm²对(11.6±4.7)个/mm²,t=2.723,P=0.010]。
- 脾切除术无效与有效ITP患者间Th17细胞计数、Treg/Th17细胞比值差异无统计学意义[(232.3±80.8)个/mm²对(239.6±66.9)个/mm²,t=1.108,P=0.277;0.040±0.024对0.053±0.027,t=0.540,P=0.592]。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To observe the quantity of Treg cells and Th17 cells in spleen of adult primary immune thrombocytopenic purpura (ITP) patients. Methods: 43 ITP cases with splenectomy treatment were enrolled from December 2008 to June 2016 at Union Hospital of Fujian Medical University, including 20 males and 23 females with a median age of 36 (18-76) years. The controls were thirty patients who underwent splenectomy because of pancreatic diseases or splenic impairment, including 21 males and 9 females with a median age of 47 (21-69) years. The quantity and ratio of Treg cells and Th17 cells were examined by immunohistochemistry between ITP patients and controls. Results: ①The quantity of Treg cells in ITP were less than controls[ (11.3±4.7) /mm(2) vs (59.0±15.0) /mm(2), t=-22.894, P<0.001], but Th17 cells were more than controls[ (235.2±69.4) /mm(2) vs (181.1±23.7) /mm(2), t=13.768, P<0.001]. So the ratio of Treg/Th17 in ITP was lower than controls (0.048±0.027 vs 0.328±0.086, t=19.522, P<0.001) . ② The quantity of Treg cells in cases without response after splenectomy were less than cases with response[ (9.5±5.0) /mm(2) vs (11.6±4.7) /mm(2), t=2.723, P=0.010], and there is no statistical differences between the two groups about the quantity of Th17 cells and the ratio of Treg/Th17 cells[ (232.3±80.8) /mm(2) vs (239.6±66.9) /mm(2), t=1.108, P=0.277; 0.040±0.024 vs 0.053±0.027, t=0.540, P=0.592]. Conclusions: There is a significant difference about the quantity of Treg cells and Th17 cells in spleen between ITP patients and healthy controls, and they are relevant to the response after splenectomy. 目的:观察成人原发免疫性血小板减少症(ITP)患者脾脏组织中调节性T细胞(Treg细胞)和Th17细胞的变化。方法: 2008年12月1日至2016年6月30日期间在福建医科大学附属协和医院接受脾切除术治疗的43例ITP患者纳入研究,男20例,女23例,中位年龄36(18~76)岁。以30例因胰腺疾病或脾外伤接受脾切除术的患者作为对照组,男21例,女9例,中位年龄47(21~69)岁。运用免疫组化技术对脾脏组织中Treg细胞和Th17细胞数量进行观察,计算Treg细胞/Th17细胞比值,分析ITP组与对照组以及脾切除有效与无效ITP患者脾脏组织中Treg、Th17细胞数量及Treg/Th17细胞比值差异。结果: ①ITP组脾脏组织中Treg细胞少于对照组[(11.3±4.7)个/mm(2)对(59.0±15.0)个/mm(2),t=-22.894,P<0.001],Th17细胞多于对照组[(235.2±69.4)个/mm(2)对(181.1±23.7)个/mm(2),t=13.768,P<0.001],Treg/Th17细胞比值低于对照组(0.048±0.027对0.328±0.086,t=19.522,P<0.001)。②脾切除术无效ITP患者脾脏组织中Treg细胞少于有效患者[(9.5±5.0)个/mm(2)对(11.6±4.7)个/mm(2),t=2.723,P=0.010],Th17细胞计数、Treg/Th17细胞比值差异无统计学意义[(232.3±80.8)个/mm(2)对(239.6±66.9)个/mm(2),t=1.108,P=0.277;0.040±0.024对0.053±0.027,t=0.540,P=0.592]。结论:成人ITP患者脾脏组织中Treg、Th17细胞数量有显著改变,可能与脾切除术疗效有一定关联。.
引用
- Yang YY, Zhang FQ, Pan Y, et al. [Quantity of Treg cells and Th17 cells in spleen of primary immune thrombocytopenic purpura patients]. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28395447. doi:10.3760/cma.j.issn.0253-2727.2017.03.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。